Summary
GW Integrative Medicine explores the connection between dolphin research and anti-aging with Fatty15 founder Stephanie Venn-Watson. The episode covers how C15:0 was identified as a longevity biomarker in dolphins and how the same fatty acid appears to play a role in healthy human aging, with connections to metabolic health, cellular resilience, and chronic disease prevention.
Key Points
- C15:0 was first identified as a longevity biomarker through dolphin health research
- The same fatty acid shows anti-aging properties in human cell studies
- Integrative medicine practitioners are exploring C15:0 as part of longevity protocols
- The dolphin-to-human translation provides a unique model for nutritional discovery
- C15:0 may support metabolic health and cellular resilience as part of aging prevention
Key Moments
Dolphins and anti-aging connections
Venn-Watson connects dolphin longevity research to human anti-aging applications through the C15:0 discovery.
"predicting a healthier aging dolphins. Instead, it was C15, this odd chain saturated fat. So it turned our attention to that and moved C15 to the lab, eight studies and three years later, it was like, wow, something that the world needs to pay attention to. So can humans get C15 from fish as well?"
